Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FGF18 mediates fibroblast-leukemia crosstalk to promote acute myeloid leukemia progression.

Blood·2026
Same author

An acoustically transmissive electrochemical vector hydrophone with horn-driven velocity amplification.

Microsystems & nanoengineering·2026
Same author

MEMS electrochemical angular accelerometer: a paradigm shift for attitude detection and control in rotorcraft UAVs.

Microsystems & nanoengineering·2026
Same author

Modular pathway engineering enables gram-scale de novo biosynthesis of narirutin in yeast.

Bioresource technology·2026
Same author

Deciphering the miRNA-TF-mRNA Regulatory Network Underlying Oocyte Maturation in Orange-Spotted Grouper (<i>Epinephelus coioides</i>): Insights from Oocyte mRNA-Seq and miRNA-Seq.

Animals : an open access journal from MDPI·2026
Same author

Clinical research advances in thoracic surgery and thoracic oncology in 2025: a panoramic narrative review.

Journal of thoracic disease·2026

Related Experiment Video

Updated: Jun 7, 2025

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
09:28

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

15.0K

High-throughput screening for optimizing adoptive T cell therapies.

Yuchen Zhang1, Qinglong Xu1, Zhifei Gao1

  • 1Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, People's Republic of China.

Experimental Hematology & Oncology
|November 14, 2024
PubMed
Summary
This summary is machine-generated.

High-throughput screening enhances adoptive T cell therapy for cancer by identifying optimal targets and treatments. This approach improves T cell therapy

Keywords:
Adoptive T cell therapiesCAR-T cellsCRISPR screeningGenetic screeningHigh-throughput screeningNon-genetic screeningTCR-T cells

More Related Videos

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

10.3K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.3K

Related Experiment Videos

Last Updated: Jun 7, 2025

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
09:28

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

15.0K
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

10.3K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.3K

Area of Science:

  • Immunotherapy
  • Genomics
  • Drug Discovery

Background:

  • Adoptive T cell therapy is a key cancer immunotherapy with significant clinical success.
  • Limited durability and primary resistance are major challenges in current T cell therapies.
  • High-throughput screening (HTS) offers a powerful approach to optimize these therapies.

Purpose of the Study:

  • To review advancements in HTS technologies for adoptive T cell therapy.
  • To explore the application of genetic and non-genetic screening in this field.
  • To guide future research and clinical applications of optimized T cell therapies.

Main Methods:

  • Examination of genetic screening approaches for T cells and tumor cells.
  • Review of non-genetic screening methods, including small molecule and targeted delivery systems.
  • Analysis of combination strategies involving HTS and adoptive T cell therapy.

Main Results:

  • HTS technologies enable selection of significant targets from large libraries.
  • Genetic screening identifies key genetic factors influencing T cell efficacy.
  • Non-genetic screening reveals novel small molecules and delivery systems for therapy enhancement.

Conclusions:

  • HTS is crucial for optimizing adoptive T cell therapy's efficacy and durability.
  • Integration of genetic and non-genetic screening strategies holds significant promise.
  • This review provides a roadmap for advancing T cell therapy through HTS.